Pharmaceuticals boost Made in Italy
On average +0.4%, with pharma up 30 points. Sector also pushing up imports in purchases (+77%).
by Luca Orlando
3' min read
3' min read
It is pharmaceuticals that decisively influenced the averages of our foreign trade in April, both incoming and outgoing. The average growth for the month of Made in Italy, up by 0.4%, was in fact affected by the rise of over 30 points in pharmaceuticals and chemical medicinal preparations, which were sold in the month for 5.7 billion euro. This figure is similar to that of imports, which grew by over 70% due to massive purchases from China and the United States in particular.
In general, while Europe advanced by two points, non-EU markets declined, with reductions in the UK, US and China in particular.
Compared to March, the Made in Italy sector is down by 2.8%. This drop, which like the modest trend growth in exports, is conditioned by the high-impact sales of seagoing craft recorded in March 2025 and April 2024: net of these, Istat estimates a smaller economic downturn (-0.6%) and more sustained trend growth (+1.7%).
In detail
In April 2025, exports (-2.8%) and imports (+0.3%) are estimated to have declined at a monthly rate. The month-on-month decrease in exports is due to the large drop in sales to the non-EU area (-7.0%), while exports to the EU area grow by 1.5%.


